iReadMore is a reading therapy for improving word reading accuracy and speed. It is a medical device for people with alexia or aphasia due to a stroke, brain injury or dementia. iReadMore was demonstrated to be clinically effective in a clinical trial.

Welcome to iReadMore! A new therapy for people with acquired language or reading impairments (called aphasia or alexia) caused by stroke, brain injury or dementia. Many people do not receive enough therapy in their rehabilitation and therefore, do not recover language abilities that they otherwise would. Unfortunately, this is even more true during the pandemic where many rehabilitation services have been severely reduced in capacity. By developing a personalised, digital therapy that can be used independently by the person with a reading impairment (achieved through co-design), we aim to offer unlimited access to a clinically-proven reading therapy that is accessible and engaging. iReadMore comes with a 7 day free trial! I'd love to hear your thoughts on the app. Feedback is much appreciated. Best, Tom 😊 PhD Student, University College London ireadmore@ucl.ac.uk

iReadMore was developed by the Neurotherapeutics Group in collaboration with software development company, Quiley Ltd (https://quiley.com/#about_me)

iReadMore: Reading Therapy

Reading therapy for stroke survivors & people with dementia

Reading therapy for stroke survivors & people with dementia